TURNOVER (x1000 EUR)
NET PROFIT (x1000 EUR)
EMPLOYEES
BioEndev AB
Closing information (x1000 EUR)
Closing information | 2023/12 | 2022/12 | 2021/12 |
Turnover |
0
|
180
|
42 |
Financial expenses |
10
|
12
|
10 |
Earnings before taxes |
417
|
-91
|
-954 |
EBITDA |
-17
|
-112
|
-944 |
Total assets |
471
|
3,015
|
4,896 |
Current assets |
434
|
2,880
|
4,750 |
Current liabilities |
10
|
396
|
1,116 |
Equity capital |
460
|
2,619
|
2,949 |
- share capital |
43
![]() |
43
|
47 |
Employees (average) |
0
|
1
|
2 |
Financial ratios
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Solvency |
97.7%
|
86.9%
|
60.2% |
Turnover per employee |
180
|
21 | |
Profit as a percentage of turnover |
-50.6%
|
-2271.4% | |
Return on assets (ROA) |
90.7%
|
-2.6%
|
-19.3% |
Current ratio |
4340.0%
|
727.3%
|
425.6% |
Return on equity (ROE) |
90.7%
|
-3.5%
|
-32.3% |
Change turnover |
-180
|
141
|
-7 |
Change turnover % |
-100%
|
364%
|
-14% |
Chg. No. of employees |
-1
![]() |
-1
![]() |
-1 |
Chg. No. of employees % |
-100%
|
-50%
|
-33% |
Total value of public sale
Fiscal year | 2023/12 | 2022/12 | 2021/12 |
Total value of public sale |
0
![]() |
0
![]() |
0 |
Closing figures are converted to the currency above at the exchange rate of the closing date. Source for the exchange rates: Sveriges Riksbank
The closing information is gathered directly from the companies or from Creditsafe.